Thermo Fisher Scientific and Cerilliant Corporation to Offer Certified Solution Standards for Forensic and Clinical Research Laboratories
News Jan 06, 2010
Scientists performing drugs of abuse analysis in forensic and clinical research laboratories currently face challenges because a large number of different testing methods are used within the industry with no standardization on reagents. Cerilliant's certified Snap-N-SpikeT/ Snap-N-Shoot® solutions for the ToxSpec Analyzer offer the industry standardized solutions that are performance tested for reliability and effectiveness. Cerilliant is a global leader in providing analytical reference standards and controls to the analytical community. The company pioneered the development of ready-to-use, solution-based reference standards provided in a shelf-stable, efficient and accurate format suitable for quantitative applications.
The ToxSpec Analyzer comprises integrated software, hardware and methodologies for forensic toxicology and simplifies the process of running assays while reducing analysis time and increasing confidence in compound identification. This new collaboration will facilitate the development of analytical methodologies designed to meet clinical research and forensic toxicology laboratories' increasingly strict regulatory requirements as well as the need to process assays in a much shorter space of time. The certified solution standards come with complete certificates of analysis and require no preparation or testing, resulting in accelerated turn-around times and significant savings.
A team of researchers has discovered a combination of pharmaceutical drugs that not only increases healthy lifespan in the microscopic worm Caenorhabditis elegans (C. elegans), but also delays the rate of ageing in them, a finding that could someday mean longer, healthier lives for humans.READ MORE
In new studies a novel oxygen-delivery therapeutic restored the function of oxygen-starved heart tissue in an animal model of global hypoxia. Unlike its experimental predecessors, the new drug does not appear to cause systemic side effects or overcorrect with excessive blood oxygenation, which can itself be toxic. Instead, the new drug delivers its precious oxygen cargo only to the tissues that need it most.READ MORE
2nd AI Pharma Innovation: Drug Discovery 2019 Summit
Feb 27 - Feb 28, 2019
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019
14th World Congress on Medicinal Chemistry and Drug Design
Jun 10 - Jun 11, 2019
International Conference on e-Health and Healthcare Innovations
May 08 - May 09, 2019